title: Evidence for increased risk of secondary graft failure after in vivo depletion of suicide gene-modified T lymphocytes transplanted in conjunction with CD34+-enriched blood stem cells.
authors.forename: Boris
authors.initials: B
authors.lastname: Fehse
authors.forename: Francis A
authors.initials: FA
authors.lastname: Ayuk
authors.forename: Nicolaus
authors.initials: N
authors.lastname: Kröger
authors.forename: Lubin
authors.initials: L
authors.lastname: Fang
authors.forename: Klaus
authors.initials: K
authors.lastname: Kühlcke
authors.forename: Marion
authors.initials: M
authors.lastname: Heinzelmann
authors.forename: Tatjana
authors.initials: T
authors.lastname: Zabelina
authors.forename: Axel A
authors.initials: AA
authors.lastname: Fauser
authors.forename: Axel R
authors.initials: AR
authors.lastname: Zander
mesh_terms: D019264:Adoptive Transfer; D000328:Adult; D018952:Antigens, CD34; D005260:Female; D041722:Genes, Transgenic, Suicide; D006084:Graft Rejection / Q000453:epidemiology*; D006086:Graft vs Host Disease / Q000453:epidemiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D033581:Stem Cell Transplantation; D013601:T-Lymphocytes / Q000502:physiology*
chemical_list: D018952:Antigens, CD34